In-person and webcast event on Sunday, 10 December, 2023 at 8:00 AM PT / 4:00 PM GMTReview of pooled analysis of the ongoing FELIX Phase Ib/II study, pooled analysis from ALLCAR19 and FELIX Phase Ib.
Final Round of Late-breaking Clinical Trial Results Announced at VIVA23 dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and.
Analyses of pooled efficacy data from the EMERGENT program demonstrate significant improvements in schizophrenia symptoms
Analyses extend prior findings that KarXT is generally well tolerated with.